RNA-binding proteins in human genetic disease

Trends in Genetics - Tập 24 - Trang 416-425 - 2008
Kiven E. Lukong1, Kai-wei Chang1, Edouard W. Khandjian2, Stéphane Richard1
1Terry Fox Molecular Oncology Group, and the Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University,Montréal, Québec H3T 1E2, Canada
2Neurobiologie Cellulaire, Centre de Recherche Robert Giffard, and Département de Biologie Médicale, Université Laval, Québec G1J 2G3, Canada

Tài liệu tham khảo

Glisovic, 2008, RNA-binding proteins and post-transcriptional gene regulation, FEBS Lett., 582, 1977, 10.1016/j.febslet.2008.03.004 Moore, 2005, From birth to death: the complex lives of eukaryotic mRNAs, Science, 309, 1514, 10.1126/science.1111443 Le Hir, 2008, EJCs at the heart of tranlational control, Cell, 133, 213, 10.1016/j.cell.2008.04.002 Keene, 2007, RNA regulons: coordination of post-transcriptional events, Nat. Rev. Genet., 8, 533, 10.1038/nrg2111 McKee, 2007, Systems perspectives on mRNA processing, Cell Res., 17, 581, 10.1038/cr.2007.54 Gerber, 2004, Extensive association of functionally and cytotopically related mRNAs with Puf family RNA-binding proteins in yeast, PLoS Biol., 2, e79, 10.1371/journal.pbio.0020079 Ule, 2003, CLIP identifies Nova-regulated RNA networks in the brain, Science, 302, 1212, 10.1126/science.1090095 Lukong, 2003, Sam68, the KH domain-containing superSTAR, Biochim. Biophys. Acta, 1653, 73 Colwill, 1996, The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution, EMBO J., 15, 265, 10.1002/j.1460-2075.1996.tb00357.x Anantharaman, 2002, Comparative genomics and evolution of proteins involved in RNA metabolism, Nucleic Acids Res., 30, 1427, 10.1093/nar/30.7.1427 Lunde, 2007, RNA-binding proteins: modular design for efficient function, Nat. Rev. Mol. Cell Biol., 8, 479, 10.1038/nrm2178 Sonenberg, 2007, New modes of translation control in development, behavior, and disease, Mol. Cell, 28, 721, 10.1016/j.molcel.2007.11.018 Matsuoka, 2007, ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage, Science, 316, 1160, 10.1126/science.1140321 de Hoog, 2004, RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers, Cell, 117, 649, 10.1016/S0092-8674(04)00456-8 Richard, 2008, Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis, Oncogene, 27, 548, 10.1038/sj.onc.1210652 Viswanathan, 2008, Selective blockade of microRNA processing by Lin28, Science, 320, 97, 10.1126/science.1154040 Lim, 2006, A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration, Cell, 125, 801, 10.1016/j.cell.2006.03.032 Gabut, 2008, SnapShot: the splicing regulatory machinery, Cell, 133, e191, 10.1016/j.cell.2008.03.010 Chelly, 2001, Monogenic causes of X-linked mental retardation, Nat. Rev. Genet., 2, 669, 10.1038/35088558 Wang, 2007, Splicing in disease: disruption of the splicing code and the decoding machinery, Nat. Rev. Genet., 8, 749, 10.1038/nrg2164 Garber, 2008, Fragile X syndrome, Eur. J. Hum. Genet., 16, 666, 10.1038/ejhg.2008.61 Penagarikano, 2007, The pathophysiology of fragile X syndrome, Annu. Rev. Genomics Hum. Genet., 8, 109, 10.1146/annurev.genom.8.080706.092249 Hagerman, 2002 Darnell, 2005, Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes, Genes Dev., 19, 903, 10.1101/gad.1276805 De Boulle, 1993, A point mutation in the FMR-1 gene associated with fragile X mental retardation, Nat. Genet., 3, 31, 10.1038/ng0193-31 Bardoni, 2006, The fragile X syndrome: exploring its molecular basis and seeking a treatment, Expert Rev. Mol. Med., 8, 1, 10.1017/S1462399406010751 Davidovic, 2007, The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules, Hum. Mol. Genet., 16, 3047, 10.1093/hmg/ddm263 Laggerbauer, 2001, Evidence that fragile X mental retardation protein is a negative regulator of translation, Hum. Mol. Genet., 10, 329, 10.1093/hmg/10.4.329 Li, 2001, The fragile X mental retardation protein inhibits translation via interacting with mRNA, Nucleic Acids Res., 29, 2276, 10.1093/nar/29.11.2276 Mazroui, 2002, Trapping of messenger RNA by fragile X mental retardation protein into cytoplasmic granules induces translation repression, Hum. Mol. Genet., 11, 3007, 10.1093/hmg/11.24.3007 Jin, 2004, RNA and microRNAs in fragile X mental retardation, Nat. Cell Biol., 6, 1048, 10.1038/ncb1104-1048 Mientjes, 2006, The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo, Neurobiol. Dis., 21, 549, 10.1016/j.nbd.2005.08.019 Bontekoe, 2002, Knockout mouse model for Fxr2: a model for mental retardation, Hum. Mol. Genet., 11, 487, 10.1093/hmg/11.5.487 Mientjes, 2004, Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo, Hum. Mol. Genet., 13, 1291, 10.1093/hmg/ddh150 Darnell, 2003, Paraneoplastic syndromes involving the nervous system, N. Engl. J. Med., 349, 1543, 10.1056/NEJMra023009 Bolognani, 2008, RNA-protein interactions and control of mRNA stability in neurons, J. Neurosci. Res., 86, 481, 10.1002/jnr.21473 Akamatsu, 2005, The RNA-binding protein HuD regulates neuronal cell identity and maturation, Proc. Natl. Acad. Sci. U. S. A., 102, 4625, 10.1073/pnas.0407523102 Bolognani, 2007, Associative and spatial learning and memory deficits in transgenic mice overexpressing the RNA-binding protein HuD, Neurobiol. Learn. Mem., 87, 635, 10.1016/j.nlm.2006.11.004 Licatalosi, 2006, Splicing regulation in neurologic disease, Neuron, 52, 93, 10.1016/j.neuron.2006.09.017 Jensen, 2000, Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability, Neuron, 25, 359, 10.1016/S0896-6273(00)80900-9 Crawford, 1996, The neurobiology of childhood spinal muscular atrophy, Neurobiol. Dis., 3, 97, 10.1006/nbdi.1996.0010 Kolb, 2007, Molecular functions of the SMN complex, J. Child Neurol., 22, 990, 10.1177/0883073807305666 Cartegni, 2002, Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1, Nat. Genet., 30, 377, 10.1038/ng854 Lorson, 1998, SMN oligomerization defect correlates with spinal muscular atrophy severity, Nat. Genet., 19, 63, 10.1038/ng0598-63 Carrel, 2006, Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis, J. Neurosci., 26, 11014, 10.1523/JNEUROSCI.1637-06.2006 McWhorter, 2003, Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding, J. Cell Biol., 162, 919, 10.1083/jcb.200303168 Monani, 2005, Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease, Neuron, 48, 885, 10.1016/j.neuron.2005.12.001 Gavrilina, 2008, Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect, Hum. Mol. Genet., 17, 1063, 10.1093/hmg/ddm379 Wheeler, 2007, Myotonic dystrophy: RNA-mediated muscle disease, Curr. Opin. Neurol., 20, 572, 10.1097/WCO.0b013e3282ef6064 Kanadia, 2006, Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy, Proc. Natl. Acad. Sci. U. S. A., 103, 11748, 10.1073/pnas.0604970103 Kuyumcu-Martinez, 2007, Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation, Mol. Cell, 28, 68, 10.1016/j.molcel.2007.07.027 Wheeler, 2007, Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy, J. Clin. Invest., 117, 3952 Jacquemont, 2007, Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1, Lancet Neurol., 6, 45, 10.1016/S1474-4422(06)70676-7 Hagerman, 2004, Fragile X-associated tremor/ataxia syndrome (FXTAS), Ment. Retard. Dev. Disabil. Res. Rev., 10, 25, 10.1002/mrdd.20005 Berry-Kravis, 2007, Fragile X-associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines, Mov. Disord., 22, 2018, 10.1002/mds.21493 Iwahashi, 2006, Protein composition of the intranuclear inclusions of FXTAS, Brain, 129, 256, 10.1093/brain/awh650 Van Dam, 2005, Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav., Brain Res., 162, 233 Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet., 18, 164, 10.1038/ng0298-164 Wahle, 1991, A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation, Cell, 66, 759, 10.1016/0092-8674(91)90119-J Abu-Baker, 2007, Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003 Dion, 2005, Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice, Neurobiol. Dis., 18, 528, 10.1016/j.nbd.2004.09.021 Hino, 2004, Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy, Hum. Mol. Genet., 13, 181, 10.1093/hmg/ddh017 Croce, 2008, Oncogenes and cancer, N. Engl. J. Med., 358, 502, 10.1056/NEJMra072367 Slamon, 1987, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, 235, 177, 10.1126/science.3798106 Schubbert, 2007, Hyperactive Ras in developmental disorders and cancer, Nat. Rev. Cancer, 7, 295, 10.1038/nrc2109 Ren, 2005, Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia, Nat. Rev. Cancer, 5, 172, 10.1038/nrc1567 Riggi, 2007, Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET, J. Pathol., 213, 4, 10.1002/path.2209 Torchia, 2007, EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice, Mol. Cell. Biol., 27, 7918, 10.1128/MCB.00099-07 Castillero-Trejo, 2005, Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors, Cancer Res., 65, 8698, 10.1158/0008-5472.CAN-05-1704 Kuroda, 2000, Male sterility and enhanced radiation sensitivity in TLS(−/−) mice, EMBO J., 19, 453, 10.1093/emboj/19.3.453 Li, 2007, Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development, J. Clin. Invest., 117, 1314, 10.1172/JCI31222 Wendel, 2007, Dissecting eIF4E action in tumorigenesis, Genes Dev., 21, 3232, 10.1101/gad.1604407 Karni, 2007, The gene encoding the splicing factor SF2/ASF is a proto-oncogene, Nat. Struct. Mol. Biol., 14, 185, 10.1038/nsmb1209 Lukong, 2005, Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression, J. Biol. Chem., 280, 38639, 10.1074/jbc.M505802200 Busa, 2007, The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells, Oncogene, 26, 4372, 10.1038/sj.onc.1210224 Chenard, 2008, New implications for the QUAKING RNA binding protein in human disease, J. Neurosci. Res., 86, 233, 10.1002/jnr.21485 Morita, 2007, One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation, Genomics, 89, 687, 10.1016/j.ygeno.2007.01.004 Bernstein, 2003, Dicer is essential for mouse development, Nat. Genet., 35, 215, 10.1038/ng1253 Kumar, 2007, Impaired microRNA processing enhances cellular transformation and tumorigenesis, Nat. Genet., 39, 673, 10.1038/ng2003 Yang, 2007, Complex seizure disorder caused by Brunol4 deficiency in mice, PLoS Genet., 3, e124, 10.1371/journal.pgen.0030124 Richard, 2005, Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss, PLoS Genet., 1, e74, 10.1371/journal.pgen.0010074 Chang, 2007, The nonsense-mediated decay RNA surveillance pathway, Annu. Rev. Biochem., 76, 51, 10.1146/annurev.biochem.76.050106.093909 Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat, Rev. Genet., 9, 102, 10.1038/nrg2290 Deo, 1999, Recognition of polyadenylate RNA by the poly(A)-binding protein, Cell, 98, 835, 10.1016/S0092-8674(00)81517-2 Musco, 1996, Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome, Cell, 85, 237, 10.1016/S0092-8674(00)81100-9 Lewis, 2000, Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome, Cell, 100, 323, 10.1016/S0092-8674(00)80668-6 Lingel, 2003, Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain, Nature, 426, 465, 10.1038/nature02123 Song, 2003, The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes, Nat. Struct. Biol., 10, 1026, 10.1038/nsb1016 Yan, 2003, Structure and conserved RNA binding of the PAZ domain, Nature, 426, 468, 10.1038/nature02129 Tuerk, 1990, Systemic evolution of ligands by expontential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science, 249, 505, 10.1126/science.2200121 Niranjanakumari, 2002, Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo, Methods, 26, 182, 10.1016/S1046-2023(02)00021-X Tenenbaum, 2002, Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays, Methods, 26, 191, 10.1016/S1046-2023(02)00022-1 Beach, 2008, Ribotrap: targeted purification of RNA-specific RNPs from cell lysates through immunoaffinity precipitation to identify regulatory proteins and RNAs, Methods Mol. Biol., 419, 69, 10.1007/978-1-59745-033-1_5 Mello, 2004, Revealing the world of RNA interference, Nature, 431, 338, 10.1038/nature02872 Blencowe, 2006, Alternative splicing: new insights from global analyses, Cell, 126, 37, 10.1016/j.cell.2006.06.023 Collins, 2002, Telomerase in the human organism, Oncogene, 21, 564, 10.1038/sj.onc.1205083 Tarpey, 2007, Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation, Nat. Genet., 39, 1127, 10.1038/ng2100 Rudnicki, 2007, Huntington's disease–like 2 is associated with CUG repeat-containing RNA foci, Ann. Neurol., 61, 272, 10.1002/ana.21081 Gatchel, 2005, Diseases of unstable repeat expansion: mechanisms and common principles, Nat. Rev. Genet., 6, 743, 10.1038/nrg1691